These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 21105218)
1. Brain neurotoxic amyloid-beta peptides: their potential role in the pathophysiology of depression and as molecular therapeutic targets. Pomara N; Sidtis JJ Br J Pharmacol; 2010 Oct; 161(4):768-70. PubMed ID: 21105218 [TBL] [Abstract][Full Text] [Related]
2. Antidepressant drugs for beta amyloid-induced depression: A new standpoint? Schiavone S; Tucci P; Mhillaj E; Bove M; Trabace L; Morgese MG Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():114-122. PubMed ID: 28499898 [TBL] [Abstract][Full Text] [Related]
3. Monoamine neurocircuitry in depression and strategies for new treatments. Hamon M; Blier P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950 [TBL] [Abstract][Full Text] [Related]
4. Neurobiology of depression and novel antidepressant drug targets. Kern N; Sheldrick AJ; Schmidt FM; Minkwitz J Curr Pharm Des; 2012; 18(36):5791-801. PubMed ID: 22681160 [TBL] [Abstract][Full Text] [Related]
5. The keys to improving depression outcomes. Rizvi SJ; Kennedy SH Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209 [TBL] [Abstract][Full Text] [Related]
6. Invited review: the evolution of antidepressant mechanisms. Slattery DA; Hudson AL; Nutt DJ Fundam Clin Pharmacol; 2004 Feb; 18(1):1-21. PubMed ID: 14748749 [TBL] [Abstract][Full Text] [Related]
7. Amyloid Hypothesis: Is There a Role for Antiamyloid Treatment in Late-Life Depression? Mahgoub N; Alexopoulos GS Am J Geriatr Psychiatry; 2016 Mar; 24(3):239-47. PubMed ID: 26946981 [TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
10. Antidepressants and the brain. Delgado P; Moreno F Int Clin Psychopharmacol; 1999 May; 14 Suppl 1():S9-16. PubMed ID: 10468323 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline and its methyl derivative in animal models of depression. Możdżeń E; Wąsik A; Romańska I; Michaluk J; Antkiewicz-Michaluk L Pharmacol Rep; 2017 Jun; 69(3):566-574. PubMed ID: 28364697 [TBL] [Abstract][Full Text] [Related]
12. Impact of some oral hypoglycemic agents on type 2 diabetes-associated depression and reserpine-induced depression in rats: the role of brain oxidative stress and inflammation. Soliman E; Essmat N; Mahmoud MF; Mahmoud AAA Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1391-1404. PubMed ID: 32077986 [TBL] [Abstract][Full Text] [Related]
13. Rodent models in depression research: classical strategies and new directions. Pollak DD; Rey CE; Monje FJ Ann Med; 2010 May; 42(4):252-64. PubMed ID: 20367120 [TBL] [Abstract][Full Text] [Related]
14. Drug Targets for Obesity and Depression: From Serotonin to Leptin. Haleem DJ Curr Drug Targets; 2016; 17(11):1282-91. PubMed ID: 26648065 [TBL] [Abstract][Full Text] [Related]
15. The PSD-95/nNOS complex: new drugs for depression? Doucet MV; Harkin A; Dev KK Pharmacol Ther; 2012 Feb; 133(2):218-29. PubMed ID: 22133842 [TBL] [Abstract][Full Text] [Related]
16. Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice. Schulte-Herbrüggen O; Vogt MA; Hörtnagl H; Gass P; Hellweg R Eur J Pharmacol; 2012 Feb; 677(1-3):77-86. PubMed ID: 22206815 [TBL] [Abstract][Full Text] [Related]